Citations (54)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Iradj Sobhani, Hugo Rotkopf & Khashayarsha Khazaie. (2020) Bacteria-related changes in host DNA methylation and the risk for CRC. Gut Microbes 12:1.
Read now
Read now
Rossana Berardi, Gaia Goteri, Alessandro Brunelli, Silvia Pagliaretta, Vittorio Paolucci, Miriam Caramanti, Silvia Rinaldi, Majed Refai, Cecilia Pompili, Francesca Morgese, Mariangela Torniai, Giulia Marcantognini, Giulia Ricci, Paola Mazzanti, Azzurra Onofri, Francesca Bianchi, Armando Sabbatini & Stefano Cascinu. (2020) Prognostic relevance of programmed cell death protein 1/programmed death-ligand 1 pathway in thymic malignancies with combined immunohistochemical and biomolecular approach. Expert Opinion on Therapeutic Targets 24:9, pages 937-943.
Read now
Read now
Meggy Suarez-Carmona, Pornpimol Chaorentong, Jakob Nikolas Kather, Rebecca Rothenheber, Azaz Ahmed, Anna Berthel, Anita Heinzelmann, Rodrigo Moraleda, Nektarios A. Valous, Zeynep Kosaloglu, Rosa Eurich, Jana Wolf, Silke Grauling-Halama, Michael Hundemer, Felix Lasitschka, Fee Klupp, Christoph Kahlert, Alexis Ulrich, Martin Schneider, Christine Falk, Dirk Jäger, Inka Zoernig & Niels Halama. (2019) CCR5 status and metastatic progression in colorectal cancer. OncoImmunology 8:9.
Read now
Read now
Claire Vanpouille-Box, Claire Lhuillier, Lucillia Bezu, Fernando Aranda, Takahiro Yamazaki, Oliver Kepp, Jitka Fucikova, Radek Spisek, Sandra Demaria, Silvia C. Formenti, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2017) Trial watch: Immune checkpoint blockers for cancer therapy. OncoImmunology 6:11.
Read now
Read now
Alejandro López-Soto, Segundo Gonzalez & Lorenzo Galluzzi. (2017) Soluble NKG2D ligands limit the efficacy of immune checkpoint blockade. OncoImmunology 6:10.
Read now
Read now
Chunwan Lu, Priscilla S. Redd, Jeffrey R. Lee, Natasha Savage & Kebin Liu. (2016) The expression profiles and regulation of PD-L1 in tumor-induced myeloid-derived suppressor cells. OncoImmunology 5:12.
Read now
Read now
Aitziber Buqué, Norma Bloy, Fernando Aranda, Isabelle Cremer, Alexander Eggermont, Wolf Hervé Fridman, Jitka Fucikova, Jérôme Galon, Radek Spisek, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2016) Trial Watch—Small molecules targeting the immunological tumor microenvironment for cancer therapy. OncoImmunology 5:6.
Read now
Read now
Mihaela Angelova, Pornpimol Charoentong, Hubert Hackl & Z. Trajanoski. (2016) The colorectal cancer immune paradox revisited. OncoImmunology 5:2.
Read now
Read now
Articles from other publishers (46)
Lei Zhou, Yuwan Zhang, Yixin Xu, Tao Jiang & Liming Tang. (2023) Identification of a novel prognostic signature composed of 3 cuproptosis-related transcription factors in colon adenocarcinoma. Genes & Genomics 45:8, pages 1047-1061.
Crossref
Crossref
Milda Rancelyte, Justinas Pamedys & Ruta Grigiene. (2023) Clinical features and treatment outcomes of progressive uveal melanoma. Archive of Clinical Cases 10:2, pages 102-106.
Crossref
Crossref
Julie Bonnereau, Tristan Courau, Nicolas Asesio, Delphine Salfati, Fatiha Bouhidel, Hélène Corte, Sarah Hamoudi, Nassim Hammoudi, Julie Lavolé, Justine Vivier-Chicoteau, Victor Chardiny, Leon Maggiori, Mathieu Blery, Romain Remark, Cécile Bonnafous, Pierre Cattan, Antoine Toubert, Purnima Bhat, Matthieu Allez, Thomas Aparicio & Lionel Le Bourhis. (2023) Autologous T cell responses to primary human colorectal cancer spheroids are enhanced by ectonucleotidase inhibition. Gut 72:4, pages 699-709.
Crossref
Crossref
SriPragnya Cheruku, Vanishree Rao, Ruchi Pandey, Mallikarjuna Rao Chamallamudi, Ravichandiran Velayutham & Nitesh Kumar. (2023) Tumor-associated macrophages employ immunoediting mechanisms in colorectal tumor progression: Current research in Macrophage repolarization immunotherapy. International Immunopharmacology 116, pages 109569.
Crossref
Crossref
Jing Zhou, Hao Guo, Likun Liu, Mali Feng, Xihua Yang & Shulan Hao. (2022) Pyroptosis patterns of colon cancer could aid to estimate prognosis, microenvironment and immunotherapy: evidence from multi-omics analysis. Aging 14:18, pages 7547-7567.
Crossref
Crossref
Ye Song, Zhipeng Zhang, Bo Zhang & Weihui Zhang. (2022) CD8+ T cell-associated genes MS4A1 and TNFRSF17 are prognostic markers and inhibit the progression of colon cancer. Frontiers in Oncology 12.
Crossref
Crossref
Mengling Wu, Qianrui Huang, Yao Xie, Xuyi Wu, Hongbo Ma, Yiwen Zhang & Yong Xia. (2022) Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation. Journal of Hematology & Oncology 15:1.
Crossref
Crossref
Guiyuan Liu, Dengxiang Lai, Yi Jiang, Hongjing Yang, Hui Zhao, Yonghui Zhang, Dan Liu & Yi Pang. (2022)
Demethylzeylasteral Exerts Antitumor Effects
via
Disruptive Autophagic Flux
and Apoptotic Cell Death in Human Colorectal Cancer Cells and Increases Cell
Chemosensitivity to 5-Fluorouracil
. Anti-Cancer Agents in Medicinal Chemistry 22:5, pages 851-863.
Crossref
Crossref
Jason Cham, Ayal Shavit, Aren Ebrahimi, Miguel Viray, Paul Gibbs & Munveer S. Bhangoo. (2021) Malignant Melanoma With Neuroendocrine Differentiation: A Case Report and Literature Review. Frontiers in Oncology 11.
Crossref
Crossref
Yan-Jie Chen, Shu-Neng Luo, Ling Dong, Tao-Tao Liu, Xi-Zhong Shen, Ning-Ping Zhang & Li Liang. (2021) Interferon regulatory factor family influences tumor immunity and prognosis of patients with colorectal cancer. Journal of Translational Medicine 19:1.
Crossref
Crossref
Jiayin Deng, Ai-Ling Tian, Hui Pan, Allan Sauvat, Marion Leduc, Peng Liu, Liwei Zhao, Shuai Zhang, Hui Chen, Valérie Taly, Pierre Laurent-Puig, Laura Senovilla, Yingqiu Li, Guido Kroemer & Oliver Kepp. (2021) Everolimus and plicamycin specifically target chemoresistant colorectal cancer cells of the CMS4 subtype. Cell Death & Disease 12:11.
Crossref
Crossref
Yimeng Ren, Yun Qian, Luoyan Ai, Yile Xie, Yaqi Gao, Ziyan Zhuang, Jinxian Chen, Ying-Xuan Chen & Jing-Yuan Fang. (2021) TRAPPC4 regulates the intracellular trafficking of PD-L1 and antitumor immunity. Nature Communications 12:1.
Crossref
Crossref
T. William MuddJrJr, Chunwan Lu, John D. Klement & Kebin Liu. (2021) MS4A1 expression and function in T cells in the colorectal cancer tumor microenvironment. Cellular Immunology 360, pages 104260.
Crossref
Crossref
Marine Fidelle, Satoru Yonekura, Marion Picard, Alexandria Cogdill, Antoine Hollebecque, Maria Paula Roberti & Laurence Zitvogel. (2020) Resolving the Paradox of Colon Cancer Through the Integration of Genetics, Immunology, and the Microbiota. Frontiers in Immunology 11.
Crossref
Crossref
Alexander R. Siebenhüner, Ulrich Güller & Rene Warschkow. (2020) Population-based SEER analysis of survival in colorectal cancer patients with or without resection of lung and liver metastases. BMC Cancer 20:1.
Crossref
Crossref
Ying Wang, Madhura S. Bhave, Hideo Yagita & Susanna L. Cardell. (2020) Natural Killer T-Cell Agonist α-Galactosylceramide and PD-1 Blockade Synergize to Reduce Tumor Development in a Preclinical Model of Colon Cancer. Frontiers in Immunology 11.
Crossref
Crossref
Niels Halama & Uwe Haberkorn. (2020) The Unmet Needs of the Diagnosis, Staging, and Treatment of Gastrointestinal Tumors. Seminars in Nuclear Medicine 50:5, pages 389-398.
Crossref
Crossref
Luoyan Ai, Antao Xu & Jie Xu. 2020. Regulation of Cancer Immune Checkpoints. Regulation of Cancer Immune Checkpoints
33
59
.
Xiang Li, Jin Xu, Lei Li, Xiaofeng Mu, Ye Wang & Xinmin Li. (2019) Evaluation of a Fully Automated Idylla Test System for Microsatellite Instability in Colorectal Cancer. Clinical Colorectal Cancer 18:4, pages e316-e323.
Crossref
Crossref
Gessani & Belardelli. (2019) Immune Dysfunctions and Immunotherapy in Colorectal Cancer: The Role of Dendritic Cells. Cancers 11:10, pages 1491.
Crossref
Crossref
Ana I. Matos, Barbara Carreira, Carina Peres, Liane I.F. Moura, João Conniot, Thibaut Fourniols, Anna Scomparin, Águeda Martínez-Barriocanal, Diego Arango, João P. Conde, Véronique Préat, Ronit Satchi-Fainaro & Helena F. Florindo. (2019) Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer. Journal of Controlled Release 307, pages 108-138.
Crossref
Crossref
Anja Schwiebs, Martina Herrero San Juan, Katrin G. Schmidt, Eliza Wiercinska, Martin Anlauf, Florian Ottenlinger, Dominique Thomas, Eiman Elwakeel, Andreas Weigert, Henner F. Farin, Halvard Bonig, Klaus Scholich, Gerd Geisslinger, Josef M. Pfeilschifter & Heinfried H. Radeke. (2019) Cancer-induced inflammation and inflammation-induced cancer in colon: a role for S1P lyase. Oncogene 38:24, pages 4788-4803.
Crossref
Crossref
Chunwan Lu, Dafeng Yang, John D. Klement, Il Kyu Oh, Natasha M. Savage, Jennifer L. Waller, Aaron H. Colby, Mark W. Grinstaff, Nicholas H. Oberlies, Cedric J. Pearce, Zhiliang Xie, Samuel K. Kulp, Christopher C. Coss, Mitch A. Phelps, Thomas Albers, Iryna O. Lebedyeva & Kebin Liu. (2019) SUV39H1 Represses the Expression of Cytotoxic T-Lymphocyte Effector Genes to Promote Colon Tumor Immune Evasion. Cancer Immunology Research 7:3, pages 414-427.
Crossref
Crossref
Devika Rao, Ruwan Parakrama, Titto Augustine, Qiang Liu, Sanjay Goel & Radhashree Maitra. (2019) Immunotherapeutic advances in gastrointestinal malignancies. npj Precision Oncology 3:1.
Crossref
Crossref
Matthieu Besneux, Alexander Greenshields-Watson, Martin J. Scurr, Bruce J. MacLachlan, Adam Christian, Michael M. Davies, Rachel Hargest, Simon Phillips, Andrew Godkin & Awen Gallimore. (2018) The nature of the human T cell response to the cancer antigen 5T4 is determined by the balance of regulatory and inflammatory T cells of the same antigen-specificity: implications for vaccine design. Cancer Immunology, Immunotherapy 68:2, pages 247-256.
Crossref
Crossref
Pawel Kalinski & Per Basse. 2019. Immune Checkpoint Inhibitors in Cancer. Immune Checkpoint Inhibitors in Cancer
1
17
.
Filip Ahlmanner, Patrik Sundström, Paulina Akeus, Jenny Eklöf, Lars Börjesson, Bengt Gustavsson, Elinor Bexe Lindskog, Sukanya Raghavan & Marianne Quiding-Järbrink. (2018) CD39+ regulatory T cells accumulate in colon adenocarcinomas and display markers of increased suppressive function. Oncotarget 9:97, pages 36993-37007.
Crossref
Crossref
Sven de Mey, Heng Jiang, Hui Wang, Benedikt Engels, Thierry Gevaert, Inès Dufait, Olivier Feron, Joeri Aerts, Valeri Verovski & Mark De Ridder. (2018) Potential of memory T cells in bridging preoperative chemoradiation and immunotherapy in rectal cancer. Radiotherapy and Oncology 127:3, pages 361-369.
Crossref
Crossref
Ellyn Hughes, Martin Scurr, Emma Campbell, Emma Jones, Andrew Godkin & Awen Gallimore. (2018) T‐cell modulation by cyclophosphamide for tumour therapy. Immunology 154:1, pages 62-68.
Crossref
Crossref
Xin Xu, Jun Wang, Kunkun Han, Shaoyan Li, Feng Xu & Yili Yang. (2018) Antimalarial drug mefloquine inhibits nuclear factor kappa B signaling and induces apoptosis in colorectal cancer cells. Cancer Science 109:4, pages 1220-1229.
Crossref
Crossref
Niels Halama. 2018. Oncoimmunology. Oncoimmunology
621
639
.
Martin Scurr, Tom Pembroke, Anja Bloom, David Roberts, Amanda Thomson, Kathryn Smart, Hayley Bridgeman, Richard Adams, Alison Brewster, Robert Jones, Sarah Gwynne, Daniel Blount, Richard Harrop, Robert Hills, Awen Gallimore & Andrew Godkin. (2017) Low-Dose Cyclophosphamide Induces Antitumor T-Cell Responses, which Associate with Survival in Metastatic Colorectal Cancer. Clinical Cancer Research 23:22, pages 6771-6780.
Crossref
Crossref
Martin Scurr, Tom Pembroke, Anja Bloom, David Roberts, Amanda Thomson, Kathryn Smart, Hayley Bridgeman, Richard Adams, Alison Brewster, Robert Jones, Sarah Gwynne, Daniel Blount, Richard Harrop, Melissa Wright, Robert Hills, Awen Gallimore & Andrew Godkin. (2017) Effect of Modified Vaccinia Ankara–5T4 and Low-Dose Cyclophosphamide on Antitumor Immunity in Metastatic Colorectal Cancer. JAMA Oncology 3:10, pages e172579.
Crossref
Crossref
Alessandra Fragale, Giulia Romagnoli, Valerio Licursi, Maria Buoncervello, Giorgia Del Vecchio, Caterina Giuliani, Stefania Parlato, Celeste Leone, Marta De Angelis, Irene Canini, Elena Toschi, Filippo Belardelli, Rodolfo Negri, Imerio Capone, Carlo Presutti & Lucia Gabriele. (2017) Antitumor Effects of Epidrug/IFNα Combination Driven by Modulated Gene Signatures in Both Colorectal Cancer and Dendritic Cells. Cancer Immunology Research 5:7, pages 604-616.
Crossref
Crossref
Emily A. Sloan, Christopher A. Moskaluk & Anne M. Mills. (2017) Mucinous Differentiation With Tumor Infiltrating Lymphocytes Is a Feature of Sporadically Methylated Endometrial Carcinomas. International Journal of Gynecological Pathology 36:3, pages 205-216.
Crossref
Crossref
Marco C. Merlano, Cristina Granetto, Elena Fea, Vincenzo Ricci & Ornella Garrone. (2017) Heterogeneity of colon cancer: from bench to bedside. ESMO Open 2:3, pages e000218.
Crossref
Crossref
Pawel Kalinski & James E. Talmadge. 2017. Tumor Immune Microenvironment in Cancer Progression and Cancer Therapy. Tumor Immune Microenvironment in Cancer Progression and Cancer Therapy
1
18
.
Fabio Gelsomino, Monica Barbolini, Andrea Spallanzani, Giuseppe Pugliese & Stefano Cascinu. (2016) The evolving role of microsatellite instability in colorectal cancer: A review. Cancer Treatment Reviews 51, pages 19-26.
Crossref
Crossref
James W.T. Toh, Paul de Souza, Stephanie H. Lim, Puneet Singh, Wei Chua, Weng Ng & Kevin J. Spring. (2016) The Potential Value of Immunotherapy in Colorectal Cancers: Review of the Evidence for Programmed Death-1 Inhibitor Therapy. Clinical Colorectal Cancer 15:4, pages 285-291.
Crossref
Crossref
A. V. Bogolyubova & P. V. Belousov. (2016) Inflammatory immune infiltration in human tumors: Role in pathogenesis and prognostic and diagnostic value. Biochemistry (Moscow) 81:11, pages 1261-1273.
Crossref
Crossref
Marco De Simone, Alberto Arrigoni, Grazisa Rossetti, Paola Gruarin, Valeria Ranzani, Claudia Politano, Raoul J.P. Bonnal, Elena Provasi, Maria Lucia Sarnicola, Ilaria Panzeri, Monica Moro, Mariacristina Crosti, Saveria Mazzara, Valentina Vaira, Silvano Bosari, Alessandro Palleschi, Luigi Santambrogio, Giorgio Bovo, Nicola Zucchini, Mauro Totis, Luca Gianotti, Giancarlo Cesana, Roberto A. Perego, Nirvana Maroni, Andrea Pisani Ceretti, Enrico Opocher, Raffaele De Francesco, Jens Geginat, Hendrik G. Stunnenberg, Sergio Abrignani & Massimiliano Pagani. (2016) Transcriptional Landscape of Human Tissue Lymphocytes Unveils Uniqueness of Tumor-Infiltrating T Regulatory Cells. Immunity 45:5, pages 1135-1147.
Crossref
Crossref
Hyo Jeong Kang, In-Seob Lee, Young-Soo Park, Won Jin Ho, DaHye Sohn, Ji-Yong Ahn, Jeong-Hwan Yook & Byung-Sik Kim. (2016) Biomarkers of EBV-positive Gastric Cancers: Loss of PTEN Expression is Associated with Poor Prognosis and Nodal Metastasis. Annals of Surgical Oncology 23:11, pages 3684-3692.
Crossref
Crossref
Kohei Tada, Shigehisa Kitano, Hirokazu Shoji, Takashi Nishimura, Yasuhiro Shimada, Kengo Nagashima, Kazunori Aoki, Nobuyoshi Hiraoka, Yoshitaka Honma, Satoru Iwasa, Natsuko Okita, Atsuo Takashima, Ken Kato, Yasuhide Yamada, Naoyuki Katayama, Narikazu Boku, Yuji Heike & Tetsuya Hamaguchi. (2016) Pretreatment Immune Status Correlates with Progression-Free Survival in Chemotherapy-Treated Metastatic Colorectal Cancer Patients. Cancer Immunology Research 4:7, pages 592-599.
Crossref
Crossref
James T. Link & Michael James Overman. (2016) Immunotherapy Progress in Mismatch Repair–Deficient Colorectal Cancer and Future Therapeutic Challenges. The Cancer Journal 22:3, pages 190-195.
Crossref
Crossref
U. Keilholz & D. Schadendorf. (2016) Blockade von ImmuncheckpointsBlockade of immune checkpoints. Forum 31:3, pages 226-229.
Crossref
Crossref
Mark J. Smyth, Shin Foong Ngiow, Antoni Ribas & Michele W. L. Teng. (2015) Combination cancer immunotherapies tailored to the tumour microenvironment. Nature Reviews Clinical Oncology 13:3, pages 143-158.
Crossref
Crossref